[News Release] saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern (Nat Commun)

Dr. Wataru Akahata of VLP Therapeutics as well as VLPT Japan and colleagues published their findings in the journal Nature Communications:

• saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
• Mai Komori+, Takuto Nogimori+, Amber L. Morey, Takashi Sekida, Keiko Ishimoto, Matthew R. Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto*, Jonathan F. Smith* & Wataru Akahata* (+ Equal contribution | *Corresponding authors)
• Nature Communications 14, Article number: 2810 (2023). https://doi.org/10.1038/s41467-023-38457-x | Published: 19 May 2023